: 25
: 52.00%
: 13
: 28.17%
: 35:53
: 9.24/3.32/9.76 (5.72)
: 652/800
: 56.4
: 8.9
: 0.977
: 0.31
: 637.0
: 150.1
: 552.3
: 19.4
Hero | Matches | Winrate | List of matches | |
---|---|---|---|---|
Morphling | 7 | 71.43% | Matches | |
Windranger | 3 | 66.67% | Matches | |
Faceless Void | 3 | 33.33% | Matches | |
Naga Siren | 2 | 0.00% | Matches | |
Slark | 2 | 0.00% | Matches | |
Anti-Mage | 1 | 100.00% | Matches | |
Luna | 1 | 0.00% | Matches | |
Bloodseeker | 1 | 100.00% | Matches | |
Lina | 1 | 100.00% | Matches | |
Wraith King | 1 | 100.00% | Matches | |
Spectre | 1 | 0.00% | Matches | |
Abaddon | 1 | 100.00% | Matches | |
Ursa | 1 | 0.00% | Matches |
Record | Match | Value | Hero |
---|---|---|---|
Kills #2 | 7506457673 - Polaris ⚔ MePa - Series 1 - Game 2 - | 24 | Morphling |
Kills #5 | 7506413333 - Polaris ⚔ MePa - Series 1 - Game 1 - | 23 | Lina |
KDA with 1+ deaths #2 | 7506457673 - Polaris ⚔ MePa - Series 1 - Game 2 - | 34 | Morphling |
KDA with 1+ deaths #5 | 7538431251 - TF ⚔ MePa - Series 2 - Game 1 - | 33 | Bloodseeker |
Damage to buildings #3 | 7524063826 - MePa ⚔ ZOL - Series 1 - Game 2 - | 27,062 | Morphling |
Damage to buildings #5 | 7503322600 - MePa ⚔ MAG.Nirvana - Series 1 - Game 1 - | 25,159 | Morphling |
Damage taken from heroes #2 | 7524063826 - MePa ⚔ ZOL - Series 1 - Game 2 - | 59,756 | Morphling |
Rampage with lowest team networth difference | 7506457673 - Polaris ⚔ MePa - Series 1 - Game 2 - | 7,632 | Morphling |
Record | Value |
---|---|
Kills #3 | 9.24 |
Least deaths #2 | 3.32 |
K/D/A #3 | 5.72 |
Average longest killstreak in match | 06:26 |
Draft stage 1 | Draft stage 2 | Draft stage 3 | |||
---|---|---|---|---|---|
Matches | Winrate | Matches | Winrate | Matches | Winrate |
1 | 0.00% | 16 | 56.25% | 8 | 50.00% |
Position | Matches | Winrate | Hero Pool | K/D/A | GPM | XPM |
---|---|---|---|---|---|---|
Core Safelane | 24 | 54.17% | 13 | 5.92 | 645 | 804 |
Core Offlane | 1 | 0.00% | 1 | 2.60 | 829 | 721 |
Team | Matches | Winrate | |
---|---|---|---|
Me Parb (MePa) | 18 | 61.11% | |
Me Parb (MeParb) | 7 | 28.57% |